.png)
4 hours ago
1
Sep 23, 2026, 09:29:17 PM IST
Indian equities ended higher on Wednesday despite intraday volatility, as markets shrugged off an intraday surge in crude and focused on signs of strengthening domestic growth momentum. Geopolitical developments at the UN General Assembly kept a risk premium embedded in oil prices, which weighed on the INR amid a firmer US dollar.
Here are 3 stock recommendations for Thursday:
2/4
Vijaya Diagnostic - Buy: 1571
Stop-loss: Rs 1495
Target: Rs 1720
Vijaya Diagnostic is exhibiting strong upward continuation on the daily timeframe, currently quoted at 1,571 after rebounding sharply from its 1,500 base to push toward multi-month highs. The stock remains positioned comfortably above its 20, 50, 100, and 200 EMAs, with all moving averages sloping positively to reflect an intact, resilient trend structure across multiple time horizons.
Sachin Gupta, VP – Technical Research at Choice Equity Broking
IANS
Stop-loss: Rs 1211
Target: Rs 1410
Olectra is showing strong signs of a bullish reversal on the daily timeframe, currently trading around 1,276 after defending the 1,180–1,200 base and surging sharply higher. The 14-period RSI has spiked to 55.61, crossing decisively above its signal line to confirm a fast-improving momentum profile as buyer’s step back in.
Sachin Gupta, VP – Technical Research at Choice Equity Broking
ANI
Stop-loss: Rs 519
Target: Rs 610
Fivestar is displaying a constructive breakout attempt on the daily chart, currently trading at 550 after rebounding sharply from its multi-week base near 520. The RSI (14) has edged up to 56.06 and holds comfortably above its signal line, reflecting steady upward momentum and positive participation from buyers.
Sachin Gupta, VP – Technical Research at Choice Equity Broking
Disclosure: This article has been written by Podishetti Akash, who is not a SEBI-registered Research Analyst or an Investment Adviser. Podishetti Akash and her ‘relative(s)’ (as defined under Section 2(77) of the Companies Act, 2013) do not hold any financial interest in the companies mentioned in this article as of the date of publication. The views/recommendations mentioned in this article, wherever applicable, are those of the respective SEBI-registered Research Analyst/brokerage and have been reproduced/reported with due attribution. They should not be construed as the views or recommendations of The Economic Times Digital or the journalist. Readers are advised to consider the original research report and make their investment decisions based on their own assessment. Brokerage disclourses here.
Agencies
English (US) ·